A pharmaceutical manufacturer has recalled a specific shipment of a meningitis vaccine as a precaution after a batch was compromised during the manufacturing process.
MENVEO lot number M16095 was recalled earlier this month by GlaxoSmithKline. It was shipped between Jan. 4 and Jan. 16. The company is asking that leftovers from the shipment be returned.
The meningitis vaccine is not a required vaccination for students in Georgia schools.
Support real journalism. Support local journalism. Subscribe to The Atlanta Journal-Constitution today. See offers.
Your subscription to the Atlanta Journal-Constitution funds in-depth reporting and investigations that keep you informed. Thank you for supporting real journalism.